Popular Articles
Stretch Mark Remedies

Empowering The Female Athlete: UPMC Sports Medicine Seeking Girls Ages 12 To 18 To Attend 'Total Package' Performance Training Conference
To bring together serious female athletes and teach them the latest injury-prevention techniques and enhance their mental training, nutrition, leadership and team-building skills, UPMC Sports Medicine is hosting Empowering the Female Athlete: ACL Injury Prevention and Beyond, June 14 to 19 at the Petersen Events Center, 3719 Terrace St., Oakland. Female athletes between ages 12 and 18 are invited to attend the conference, led by a range of UPMC experts who care for all types of patients, including scholastic and professional athletes.
generic viagra online
UPMC Senior Community, Heritage Place, Wins National Activity Services Award
Heritage Place, a UPMC Senior Community, has been awarded Activity Department of the Year for 2009 by the National Certification Council for Activity Professionals.
News of the day
Pope, Obama To Hold Meeting After G-8 Summit
Pope Benedict XVI has agreed to meet with President Obama at the Vatican on July 10, according to White House spokesperson Robert Gibbs, the AP/Boston Globe reports. The Rev. Federico Lombardi, a Vatican spokesperson, on Wednesday said that the pope will hold an afternoon meeting with the president and first lady Michelle Obama after the conclusion of the Group of Eight industrialized nations summit meeting, a break with a Vatican tradition of holding midday meetings. The AP/Globe reports that the Vatican "clearly sought to accommodate" the president"s schedule, an indication that Benedict is interested in meeting with Obama despite his support for abortion rights and embryonic stem cell research.Some U.S. bishops have publicly attacked Obama"s support of abortion rights and embryonic stem cell research, which has fueled anticipation of a meeting between the president and the pope. Most recently, dozens of bishops denounced the University of Notre Dame"s decision to invite Obama to deliver its commencement address and receive an honorary degree. However, L"Osservatore Romano, the Vatican"s daily newspaper, said that Obama"s speech showed that he is looking for common ground on issues related to abortion. Obama also received a positive review from the newspaper after his first 100 days in office. An editorial in the paper said that Obama had not confirmed the "radical" direction on ethical questions he had discussed as a candidate (Simpson, AP/Boston Globe, 6/24).
Medical Devices

Enzyme Fights Mutated Protein In Inherited Parkinson's Disease

An enzyme that naturally occurs in the brain helps destroy the mutated protein that is the most common cause of inherited Parkinson"s disease, researchers at UT Southwestern Medical Center have found. Their study, using human cells, provides a focus for further research into halting the action of the mutated protein. One of the most famous carriers of the mutation is Google co-founder Sergey Brin, who wrote about it on his blog in 2008. "There are currently enormous efforts to identify potential therapies based on inhibiting this mutated protein," said Dr. Matthew Goldberg, assistant professor of neurology and psychiatry and senior author of the paper, which appears online in the journal Public Library of Science. "Our paper is a major advance because we identify a protein that binds to the mutated protein and promotes its breakdown," he said. The particular mutation that they studied affects a protein whose function is not well understood. In its normal form, it appears to have multiple sites where other molecules can attach themselves, like a space station with many docking areas. Several mutations can affect the protein, which is named LRRK2. Some of the mutations cause Parkinson"s disease. The current theory is that the mutation leads to increased function of LRRK2 and to the formation of abnormal clumps of proteins inside brain nerve cells. The cells eventually die from these effects. In the current study, the researchers used cultured human kidney cells and found that LRRK2 and a protein called CHIP "robustly" associated with each other. Further testing showed that CHIP and LRRK2 could bind to each other in two different ways, either directly or indirectly by a third molecule that acted as a bridge. When CHIP bound to either the normal or mutant form of LRRK2, levels of LRRK2 in the cell decreased, the researchers found. This occurred because the cells increased the rate at which they destroyed LRRK2. "CHIP may be a useful therapeutic target for treatments to break down LRRK2 in people with Parkinson"s," Dr. Goldberg said. "Our next step is to identify cellular mechanisms that signal LRRK2 to be degraded by CHIP or by other mechanisms," he said. "Because LRRK2 mutations are believed to cause Parkinsonism by increasing the activity of LRRK2, enhancing the normal mechanisms that target LRRK2 for degradation by CHIP may be therapeutically beneficial." Lead author Xiaodong Ding, senior research associate in neurology at UT Southwestern, also contributed to the study. The study was funded in part by the David M. Crowley Foundation. UT Southwestern Medical Center


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):